Research Article

Dahuang Zhechong Pill Combined with Doxorubicin Induces Cell Death through Regulating Energy Metabolism in Human Hepatocellular Carcinoma Cells

Figure 1

Effects of DHZCP-medicated serum combined with DOX on SMMC-7721 cell viability. (a) CCK-8 assay for evaluating cell viability. (b) Changes of cell configuration of SMMC-7721 treated with DHZCP-medicated serum and/or DOX. Groups: (1) control; (2) DHZCP-medicated serum; (3)–(5) DOX (0.5, 2, and 8 μM); (6)–(8) combination of DHZCP-medicated serum with DOX (0.5, 2, and 8 μM). Significance: , in comparison with control; , compared with DOX group.
(a)
(b)